Clinical Trial Update: Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing ethosuximide for chemotherapy-induced painful peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Peripheral Neuropathy

Drugs mentioned

• Ethosuximide (ethosuximide)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Cancer, Peripheral Neuropathy | Phase 2 | Status: COMPLETED